Project profile — Support to COVID-19 Medical Oxygen Response

• Africa, regional (20.00%)
• America, regional (20.00%)
• Asia, regional (20.00%)
• Oceania, regional (20.00%)
• Europe, regional (20.00%)

• Basic Health: Infectious disease control (12250) (50.00%)
• Health: COVID-19 control (12264) (50.00%)

• Gender equality (significant objective)
• Environmental sustainability (cross-cutting) (not targeted)
• Participatory development and good governance (not targeted)
• Trade development (not targeted)
• Biodiversity (not targeted)
• Climate change mitigation (not targeted)
• Climate Change Adaptation (not targeted)
• Urban issues (not targeted)
• Desertification (not targeted)
• Children's issues (not targeted)
• Youth Issues (not targeted)
• Disaster Risk Reduction(DRR) (not targeted)
• Indigenous Issues (not targeted)
• Disability (not targeted)
• Nutrition (not targeted)
• ICT as a tool for development (not targeted)

This project aims to support Unitaid in advancing equitable and affordable access to medical oxygen for COVID-19 treatments in low- and middle-income countries. The support comes through market interventions to increase the supply and adoption of oxygen innovations and investments in sustainable delivery models. As a result, the project increases the national oxygen systems’ capacity and enables national health systems to treat chronic respiratory conditions such as COVID-19. Project activities include: (1) identifying local and regional liquid and gas suppliers to increase the availability and affordability of medical oxygen for public procurers; (2) supporting sustainable market entry for new medical oxygen suppliers through blended finance approaches; (3) piloting local and regional supply approaches in sub-Saharan Africa; (4) identifying and piloting appropriate, high-impact oxygen innovations and technologies adapted for low-resource settings; and (5) generating and disseminating evidence, including operational guidance.

The expected outcomes of this project include an increased capacity of oxygen produced and delivered to low- and middle-income countries.

N/A

• Proactive disclosure